Bagsværd, Denmark, 31 July 2026 – Novo Nordisk today announced headline results from the ZEUS cardio...
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
Bagsværd, Denmark, 31 July 2026 – Novo Nordisk today announced headline results from the ZEUS cardiovascular outcomes phase 3 trial.
Author: finance.yahoo.com
Read Original Article